Back
Keros Therapeutics Vs. Digimarc Industry Stock Comparison
Sell
14
KROS
Keros Therapeutics
Last Price:
$15.85
Seasonality Move:
10.52%
Buy
69
DMRC
Digimarc
Last Price:
$47.29
Seasonality Move:
-0.46%
Sell
14
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
-
The current Keros Therapeutics [KROS] share price is $15.84. The Score for KROS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $15.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
DMRC Stock Price Chart
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.8 | Sell |
Relative Strength Index (14 RSI): | 23.31 | Sell |
Chaikin Money Flow: | -399504 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.69 - 55.21) | Sell |
Bollinger Bands (100): | (34.21 - 66.59) | Sell |
DMRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.95 | Buy |
Relative Strength Index (14 RSI): | 77.81 | Buy |
Chaikin Money Flow: | -50271 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.04 - 41.56) | Buy |
Bollinger Bands (100): | (26.95 - 36.11) | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.03 | Sell |
20-day SMA: | 24.49 | Sell |
50-day SMA: | 46.19 | Sell |
200-day SMA: | 51.32 | Sell |
8-day EMA: | 16.77 | Sell |
20-day EMA: | 24.91 | Sell |
50-day EMA: | 38.74 | Sell |
200-day EMA: | 48.51 | Sell |
DMRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.75 | Buy |
20-day SMA: | 38.6 | Buy |
50-day SMA: | 34.92 | Buy |
200-day SMA: | 29.48 | Buy |
8-day EMA: | 42.91 | Buy |
20-day EMA: | 39.47 | Buy |
50-day EMA: | 35.85 | Buy |
200-day EMA: | 31.56 | Buy |
Keros Therapeutics Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.82 per share.
Digimarc Earnings Growth & DMRC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and a decrease next year of $0.00 per share.
Keros Therapeutics Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Digimarc Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |